People: Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

103.36USD
2 Sep 2014
Price Change (% chg)

$-0.37 (-0.36%)
Prev Close
$103.73
Open
$103.38
Day's High
$103.68
Day's Low
$103.04
Volume
1,495,503
Avg. Vol
1,817,468
52-wk High
$106.74
52-wk Low
$85.50

Search Stocks

Washington, A. Eugene 

Brief Biography

Dr. A. Eugene Washington, M.D. has been appointed as an Independent Director of Johnson & Johnson, effective November 09, 2012. Dr. Washington is a member of the Science, Technology & Sustainability Committee and the Regulatory, Compliance & Government Affairs Committee. Dr. Washington is currently Vice Chancellor of Health Sciences, Dean of the David Geffen School of Medicine at UCLA; Chief Executive Officer of the UCLA Health System; and Distinguished Professor of Gynecology and Health Policy at UCLA. Prior to UCLA, he served as Executive Vice Chancellor and Provost at the University of California, San Francisco (UCSF) from 2004 to 2010. Dr. Washington co-founded UCSF’s Medical Effectiveness Research Center for Diverse Populations in 1993 and served as the director until 2005. He was Chair of the Department of Obstetrics, Gynecology, and Reproductive Sciences at UCSF from 1996 to 2004. Dr. Washington also co-founded the UCSF-Stanford Evidence-based Practice Center and served as its first director from 1997 to 2002. Prior to UCSF, Dr. Washington worked at the Centers for Disease Control and Prevention. Dr. Washington was elected to the National Academy of Sciences’ Institute of Medicine in 1997, where he served on its governing Council. He also served as Chair of the Board of Directors of the California HealthCare Foundation, as a member of the Scientific Management Review Board for the National Institutes of Health, and as founding Chair of the Board of Governors of the Patient-Centered Outcomes Research Institute. Dr. Washington is currently Vice Chairman of the Board of Directors of The California Wellness Foundation.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Alex Gorsky

16,911,000

Dominic Caruso

8,233,320

Sandra Peterson

5,637,260

Paulus Stoffels

7,822,000

Michael Ullmann

4,363,340

Peter Fasolo

3,621,280
As Of 28 Dec 2013
Search Stocks